Latest Breaking News On - Important information about the recapitalization share exchange - Page 1 : comparemela.com

Allarity Therapeutics Announces Shareholder Acceptance of

Press release Hørsholm, Denmark (December 11, 2021) Allarity Therapeutics A/S (“Allarity A/S” or the “Company”) today announced that in.

United statesThomas pedersenMike beyerChuck padalaJens knudsenCompany board of directorsImportant information about the recapitalization share exchangeCompany contactCarrotize pr communicationsSam brown incExchange commissionLantern pharma incAllarity therapeutics incSmerud medical research internationalAllarity therapeuticsShare swap offer

Allarity Therapeutics A/S Publishes Offer Document Offering to Acquire Company Shares in Exchange for Shares in Allarity Therapeutics, Inc with the Intent to Complete Recapitalization

24.11.2021 - Press release Hørsholm, Denmark (November 24, 2021) Allarity Therapeutics A/S ( Allarity A/S or the Company ) hereby announces a voluntary offer and offer document to the shareholders of Allarity A/S to acquire all shares in Allarity A/S (the .

United statesSteve carchediThomas pedersenMike beyerImportant information about the recapitalization share exchangeCarrotize pr communicationsExchange ratioAllarity delaware the exchange ratioSam brown incExchange commissionLantern pharma incAllarity therapeutics incSmerud medical research internationalTender periodAllarity delawareOffer document

U S SEC Issues Order Declaring Allarity Therapeutics Inc s Form S-4 Registration Statement Effective Ahead of Planned Transition to U S Nasdaq

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesThomas pedersenMike beyerUs securities exchange commissionImportant information about the recapitalization share exchangeRecapitalization share exchangeCarrotize pr communicationsCompany recapitalization share exchangeSam brown incExchange commissionLantern pharma incAllarity therapeutics incAllarity therapeuticsRecapitalization shareConvening noticeNasdaq capital market

Allarity Therapeutics A/S : Announces Extraordinary Exercise Period for Warrants of Series ALLR TO 3 Set to August 30 – September 13, 2021

Press Release Hørsholm, Denmark – Allarity Therapeutics A/S today announces that an accelerated extraordinary and final exercise period for warrants of the ALLR TO 3 series , which. | August 27, 2021

New yorkUnited statesMazanti andersen advokatpartnerselskabThomas pedersenHagberg aneborn fondkommissionImportant information about the recapitalization share exchangeCompany board of directorsCarrotize pr communicationsAllarity pressExchange commissionDanish business authorityLantern pharma incAllarity therapeutics incEu pressSmerud medical research internationalAneborn fondkommission

Allarity Therapeutics A/S : Files Form S-4 Registration Statement with U S Securities & Exchange Commission (SEC) for Listing on U S Nasdaq

Allarity Therapeutics A/S : Files Form S-4 Registration Statement with U S Securities & Exchange Commission (SEC) for Listing on U S Nasdaq
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesScott bartelLos angelesSteve carchediThomas pedersenMike beyerRecapitalization share exchangeSam brown incAllarity us incLantern pharma incAllarity therapeutics incEu pressSmerud medical research internationalAllarity press releaseLewis brisbois bisgaard smith